Quick Takeaways
- Samuel Agresta has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $183,600.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Samuel Agresta
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Samuel Agresta is at least $183,600 dollars as of 03 Apr 2026. Samuel Agresta is the Chief Medical Officer of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $183.6K.
- Signature
- /s/ Rogan Nunn, by power of attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Samuel Agresta and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Foghorn Therapeutics Inc. ($183,600).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Samuel Agresta
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | Chief Medical Officer | $183,600 | 11 Sep 2023 | ||
| INFI | INFINITY PHARMACEUTICALS, INC. | Director | 16 Jun 2022 | |||
| OKUR | OnKure Therapeutics, Inc. | Chief Medical Officer | 01 Apr 2026 |
Insider Transactions Reported by Samuel Agresta:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.